Tandem Diabetes Care (TNDM) Inventory Average (2014 - 2026)

Tandem Diabetes Care has reported Inventory Average for 13 years, with the latest figure at $127.6 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average fell 12.25% year-over-year to $127.6 million; the trailing twelve-month figure through Mar 2026 stood at $127.6 million (down 12.25% YoY), and the FY2025 full-year result was $139.2 million, down 9.48% from the prior year.
• Inventory Average for Q1 2026 stood at $127.6 million, down from $133.0 million in the prior quarter.
• The five-year high for Inventory Average was $157.8 million in Q2 2024, with the low at $74.3 million in Q1 2022.
• Historically, Inventory Average has averaged $131.1 million across 5 years, with a median of $139.9 million in 2025.
• Annual changes were most pronounced in 2023 — Inventory Average soared 66.08% — and 2026, when it decreased 12.25%.
• Tandem Diabetes Care's Inventory Average stood at $107.9 million in 2022, then soared by 39.62% to $150.7 million in 2023, then climbed by 0.21% to $151.0 million in 2024, then declined by 11.92% to $133.0 million in 2025, then declined by 4.09% to $127.6 million in 2026.
• The last three Inventory Average figures came in at $127.6 million (Q1 2026), $133.0 million (Q4 2025), and $139.9 million (Q3 2025), per Business Quant data.